MEI Pharma Inc (MEIP)
3.25
-0.06
(-1.81%)
USD |
NASDAQ |
Apr 18, 16:00
3.35
+0.10
(+3.08%)
After-Hours: 20:00
MEI Pharma Free Cash Flow (Quarterly): -11.06M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.06M |
| September 30, 2023 | -18.49M |
| June 30, 2023 | -11.34M |
| March 31, 2023 | -12.13M |
| December 31, 2022 | -14.21M |
| September 30, 2022 | -14.84M |
| June 30, 2022 | -15.81M |
| March 31, 2022 | -17.07M |
| December 31, 2021 | -8.617M |
| September 30, 2021 | -7.729M |
| June 30, 2021 | -11.26M |
| March 31, 2021 | -15.65M |
| December 31, 2020 | 3.994M |
| September 30, 2020 | -9.755M |
| June 30, 2020 | 69.00M |
| March 31, 2020 | -11.08M |
| December 31, 2019 | -10.49M |
| September 30, 2019 | -14.08M |
| June 30, 2019 | -8.074M |
| March 31, 2019 | -11.38M |
| December 31, 2018 | 2.627M |
| September 30, 2018 | -12.82M |
| June 30, 2018 | -3.483M |
| March 31, 2018 | -6.239M |
| December 31, 2017 | -4.751M |
| Date | Value |
|---|---|
| September 30, 2017 | -6.562M |
| June 30, 2017 | -3.195M |
| March 31, 2017 | 1.606M |
| December 31, 2016 | -3.747M |
| September 30, 2016 | 8.771M |
| June 30, 2016 | -3.484M |
| March 31, 2016 | -4.388M |
| December 31, 2015 | -4.228M |
| September 30, 2015 | -5.761M |
| June 30, 2015 | -6.741M |
| March 31, 2015 | -8.154M |
| December 31, 2014 | -6.458M |
| September 30, 2014 | -6.731M |
| June 30, 2014 | -5.879M |
| March 31, 2014 | -5.087M |
| December 31, 2013 | -4.466M |
| September 30, 2013 | -4.069M |
| June 30, 2013 | -2.776M |
| March 31, 2013 | -2.655M |
| December 31, 2012 | -2.162M |
| September 30, 2012 | -2.489M |
| June 30, 2012 | -1.304M |
| March 31, 2012 | -2.273M |
| December 31, 2011 | -1.774M |
| September 30, 2011 | -1.73M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-18.49M
Minimum
Sep 2023
69.00M
Maximum
Jun 2020
-7.299M
Average
-11.26M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
| Merck & Co Inc | -743.00M |
| United Therapeutics Corp | 72.00M |
| Macrogenics Inc | -28.66M |
| Voyager Therapeutics Inc | -24.52M |
| Moderna Inc | 402.00M |